Which has the lower trailing P/E, GMED or PEN?

GMED has the lower trailing P/E: GMED trades at 21.22 and PEN at 78.87. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, GMED or PEN?

Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus PEN at 17.52%.

Is GMED or PEN more profitable?

GMED runs the higher net margin — GMED at 17.03% versus PEN at 10.67%.

How have GMED and PEN total returns compared?

Over the past 10 years, GMED delivered 13.76% and PEN delivered 16.16% annualized total return. Past performance doesn't predict future results.

Globus Medical, Inc. (GMED) vs Penumbra, Inc. (PEN)

A side-by-side comparison of Globus Medical, Inc. and Penumbra, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

GMED

Globus Medical, Inc.

$11.13B

$82.54HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

PEN

Penumbra, Inc.

$12.64B

$321.00HealthcareDelayed quote: Aug 27, 2026, 4:00 PM EDT

Total return — GMED vs PEN

growth of $100 · dividends reinvested · last 10y

GMED +257.6% (+13.6%/yr)PEN +347.3% (+16.2%/yr)PEN compounded faster over this window

GMED PEN

GMED vs PEN: by the numbers

•PEN is the larger company ($12.64B vs $11.13B market cap).
•GMED trades at the lower trailing earnings multiple (21.22 vs 78.87 P/E), one valuation lens rather than an overall verdict.
•GMED converts more revenue to profit (17.03% vs 10.67% net margin).
•GMED grew revenue faster over the past five years (27.65% vs 17.52% CAGR).

Metrics side by side

Valuation

Metric	GMED	PEN
P/E ratio	21.22	78.87
Forward P/E	16.57	68.18
P/S ratio	3.63	8.44
P/B ratio	2.39	8.30
EV / EBITDA	11.79	62.16
FCF yield	6.58%	1.70%

Profitability

Metric	GMED	PEN
Gross margin	68.55%	67.84%
Operating margin	20.75%	12.45%
Net margin	17.03%	10.67%
ROE	11.23%	10.49%
ROIC	10.49%	8.48%

Growth (annualized)

Metric	GMED	PEN
Revenue CAGR (5Y)	27.65%	17.52%
EPS CAGR (5Y)	30.79%	21.94%
FCF CAGR (5Y)	29.93%	83.74%
Total return CAGR (5Y)	0.22%	3.38%

Frequently asked

Which has the lower trailing P/E, GMED or PEN?: GMED has the lower trailing P/E: GMED trades at 21.22 and PEN at 78.87. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, GMED or PEN?: Over the past five years, GMED grew revenue faster — GMED at a 27.65% CAGR versus PEN at 17.52%.
Is GMED or PEN more profitable?: GMED runs the higher net margin — GMED at 17.03% versus PEN at 10.67%.
How have GMED and PEN total returns compared?: Over the past 10 years, GMED delivered 13.76% and PEN delivered 16.16% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GMED analysis Full PEN analysis Interactive comparison tool

Dig into the metrics

Globus Medical P/E ratio Penumbra P/E ratio Globus Medical ROE Penumbra ROE Globus Medical operating margin Penumbra operating margin Globus Medical revenue growth Penumbra revenue growth Globus Medical free cash flow Penumbra free cash flow

Globus Medical & Penumbra appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.